 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
The Journal of Neuroscience, January 10, 2007, 27(2):422-430; doi:10.1523/JNEUROSCI.4798-06.2007
Previous Article | Next Article
Neurobiology of Disease
Altered Axonal Mitochondrial Transport in the Pathogenesis of Charcot-Marie-Tooth Disease from Mitofusin 2 Mutations
Robert H. Baloh,1,3 Robert E. Schmidt,2 Alan Pestronk,1,3 andJeffrey Milbrandt1,2,3 Departments of 1Neurology and 2Pathology and 3Hope Center for Neurological Diseases, Washington University School of Medicine, St. Louis, Missouri 63110
Correspondence should be addressed to Robert H. Baloh, Department of Neurology, Washington University School of Medicine, P.O. Box 8111, 660 South Euclid Avenue, St. Louis, MO 63110. Email: balohb{at}neuro.wustl.edu
Mutations in the mitochondrial fusion protein mitofusin 2 (MFN2) are the most commonly identified cause of Charcot-Marie-Tooth type 2 (CMT2), a dominantly inherited disease characterized by degeneration of peripheral sensory and motor axons. However, the mechanism by which mutations in this ubiquitously expressed mitochondrial fusion protein lead to neuropathy has not yet been elucidated. To explore how MFN2 mutations lead to degeneration of peripheral axons, we expressed neuropathy-associated forms of MFN2 in cultured dorsal root ganglion neurons, cells preferentially affected in CMT2. Disease-associated MFN2 mutant proteins induced abnormal clustering of small fragmented mitochondria in both neuronal cell bodies and proximal axons. Interestingly, transport of mitochondria in axons was significantly impaired in neurons expressing disease-mutated forms of MFN2. The diminished axonal mitochondrial transport was not attributable to diminished ATP levels in the neurons, and oxidative respiration was normal in mutant MFN2-expressing cells. Additionally, mitochondrial oxidative enzyme activity was normal in muscle mitochondria from a CMT2 patient with an MFN2 mutation, further supporting that abnormal mitochondrial transport in neurons is independent from an energy production defect. This abnormal mitochondrial trafficking provides a likely explanation for the selective susceptibility of the longest peripheral axons to MFN2 mutations, in which proper localization of mitochondria is critical for axonal and synaptic function.
Key words: axon; axonal transport (axoplasmic transport); genetics; mitochondria; neuropathy; trafficking
Received Nov. 3, 2006; revised Dec. 4, 2006; accepted Dec. 5, 2006.
Correspondence should be addressed to Robert H. Baloh, Department of Neurology, Washington University School of Medicine, P.O. Box 8111, 660 South Euclid Avenue, St. Louis, MO 63110. Email: balohb{at}neuro.wustl.edu
Related articles in J. Neurosci.:
- This Week in The Journal
J. Neurosci. 2007 27: i.[Full Text]
This article has been cited by other articles:
C. L. Zhang, P. L. Ho, D. B. Kintner, D. Sun, and S. Y. Chiu
Activity-Dependent Regulation of Mitochondrial Motility by Calcium and Na/K-ATPase at Nodes of Ranvier of Myelinated Nerves
J. Neurosci., March 10, 2010; 30(10): 3555 - 3566.
[Abstract] [Full Text] [PDF]
M M Reilly and M E Shy
Diagnosis and new treatments in genetic neuropathies
J. Neurol. Neurosurg. Psychiatry, December 1, 2009; 80(12): 1304 - 1314.
[Abstract] [Full Text] [PDF]
E. A. Amiott, M. M. Cohen, Y. Saint-Georges, A. M. Weissman, and J. M. Shaw
A Mutation Associated with CMT2A Neuropathy Causes Defects in Fzo1 GTP Hydrolysis, Ubiquitylation, and Protein Turnover
Mol. Biol. Cell, December 1, 2009; 20(23): 5026 - 5035.
[Abstract] [Full Text] [PDF]
L. Chen, Q. Gong, J. P. Stice, and A. A. Knowlton
Mitochondrial OPA1, apoptosis, and heart failure
Cardiovasc Res, October 1, 2009; 84(1): 91 - 99.
[Abstract] [Full Text] [PDF]
R. Perrot and J.-P. Julien
Real-time imaging reveals defects of fast axonal transport induced by disorganization of intermediate filaments
FASEB J, September 1, 2009; 23(9): 3213 - 3225.
[Abstract] [Full Text] [PDF]
M. Liesa, M. Palacin, and A. Zorzano
Mitochondrial Dynamics in Mammalian Health and Disease
Physiol Rev, July 1, 2009; 89(3): 799 - 845.
[Abstract] [Full Text] [PDF]
P Yu-Wai-Man, P G Griffiths, G Hudson, and P F Chinnery
Inherited mitochondrial optic neuropathies
J. Med. Genet., March 1, 2009; 46(3): 145 - 158.
[Abstract] [Full Text] [PDF]
R. D. Bo, M. Moggio, M. Rango, S. Bonato, M. G. D'Angelo, S. Ghezzi, G. Airoldi, M. T. Bassi, M. Guglieri, L. Napoli, et al.
Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction
Neurology, December 9, 2008; 71(24): 1959 - 1966.
[Abstract] [Full Text] [PDF]
M. Spinazzi, S. Cazzola, M. Bortolozzi, A. Baracca, E. Loro, A. Casarin, G. Solaini, G. Sgarbi, G. Casalena, G. Cenacchi, et al.
A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function
Hum. Mol. Genet., November 1, 2008; 17(21): 3291 - 3302.
[Abstract] [Full Text] [PDF]
X. Zhang, C. Y. Chow, Z. Sahenk, M. E. Shy, M. H. Meisler, and J. Li
Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration
Brain, August 1, 2008; 131(8): 1990 - 2001.
[Abstract] [Full Text] [PDF]
C. Press and J. Milbrandt
Nmnat Delays Axonal Degeneration Caused by Mitochondrial and Oxidative Stress
J. Neurosci., May 7, 2008; 28(19): 4861 - 4871.
[Abstract] [Full Text] [PDF]
G. A. Nicholson, C. Magdelaine, D. Zhu, S. Grew, M. M. Ryan, F. Sturtz, J. -M. Vallat, and R. A. Ouvrier
Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations
Neurology, May 6, 2008; 70(19): 1678 - 1681.
[Abstract] [Full Text] [PDF]
S. A. Detmer, C. V. Velde, D. W. Cleveland, and D. C. Chan
Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot-Marie-Tooth type 2A
Hum. Mol. Genet., February 1, 2008; 17(3): 367 - 375.
[Abstract] [Full Text] [PDF]
R. H. Baloh
Mitochondrial Dynamics and Peripheral Neuropathy
Neuroscientist, February 1, 2008; 14(1): 12 - 18.
[Abstract] [PDF]
|
|
|
|
 |
|